Article
Androgen axis in prostate cancer.
Journal of cellular biochemistry - 1 Oct 2006
Culig Zoran, Bartsch Georg
Abstract excerpt
Endocrine therapy for advanced prostate cancer is based on androgen ablation or blockade of the androgen receptor (AR). AR action in prostate cancer has been investigated in a number of cell lines, their derivatives, and transgenic animals. AR expression is heterogenous in prostate cancer in vivo; it could be detected in most primary tumors and their metastases. However, some cells lack the AR because of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
